Preparation of Benzothiazolyl-Decorated Nanoliposomes
- PMID: 31003552
- PMCID: PMC6514897
- DOI: 10.3390/molecules24081540
Preparation of Benzothiazolyl-Decorated Nanoliposomes
Abstract
Amyloid β (Aβ) species are considered as potential targets for the development of diagnostics/therapeutics towards Alzheimer's disease (AD). Nanoliposomes which are decorated with molecules having high affinity for Aβ species may be considered as potential carriers for AD theragnostics. Herein, benzothiazolyl (BTH) decorated nanoliposomes were prepared for the first time, after synthesis of a lipidic BTH derivative (lipid-BTH). The synthetic pathway included acylation of bis(2-aminophenyl) disulfide with palmitic acid or palmitoyl chloride and subsequent reduction of the oxidized dithiol derivative. The liberated thiols were able to cyclize to the corresponding benzothiazolyl derivatives only after acidification of the reaction mixture. Each step of the procedure was monitored by HPLC analysis in order to identify all the important parameters for the formation of the BTH-group. Finally, the optimal methodology was identified, and was applied for the synthesis of the lipid-BTH derivative. BTH-decorated nanoliposomes were then prepared and characterized for physicochemical properties (size distribution, surface charge, physical stability, and membrane integrity during incubation in presence of buffer and plasma proteins). Pegylated BTH-nanoliposomes were demonstrated to have high integrity in the presence of proteins (in comparison to non-peglated ones) justifying their further exploitation as potential theragnostic systems for AD.
Keywords: amyloid β; benzothiazoles; functionalization; nanoliposomes; targeting.
Conflict of interest statement
The authors declare no conflict of interest.
Figures











Similar articles
-
Liposomes Decorated with 2-(4'-Aminophenyl)benzothiazole Effectively Inhibit Aβ1-42 Fibril Formation and Exhibit in Vitro Brain-Targeting Potential.Biomacromolecules. 2020 Dec 14;21(12):4685-4698. doi: 10.1021/acs.biomac.0c00811. Epub 2020 Oct 28. Biomacromolecules. 2020. PMID: 33112137
-
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue.Biomaterials. 2011 Aug;32(23):5489-97. doi: 10.1016/j.biomaterials.2011.04.020. Epub 2011 May 6. Biomaterials. 2011. PMID: 21529932
-
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide.J Biotechnol. 2011 Dec 20;156(4):341-6. doi: 10.1016/j.jbiotec.2011.06.037. Epub 2011 Jul 6. J Biotechnol. 2011. PMID: 21763360
-
Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43. doi: 10.1016/j.ejpb.2013.07.002. Epub 2013 Jul 17. Eur J Pharm Biopharm. 2013. PMID: 23872180 Review.
-
Prospects and challenges of synergistic effect of fluorescent carbon dots, liposomes and nanoliposomes for theragnostic applications.Photodiagnosis Photodyn Ther. 2023 Jun;42:103614. doi: 10.1016/j.pdpdt.2023.103614. Epub 2023 May 16. Photodiagnosis Photodyn Ther. 2023. PMID: 37201772 Review.
Cited by
-
Liposome based drug delivery as a potential treatment option for Alzheimer's disease.Neural Regen Res. 2022 Jun;17(6):1190-1198. doi: 10.4103/1673-5374.327328. Neural Regen Res. 2022. PMID: 34782553 Free PMC article. Review.
-
Synthesis of Novel Arsonolipids and Development of Novel Arsonoliposome Types.Pharmaceutics. 2022 Aug 8;14(8):1649. doi: 10.3390/pharmaceutics14081649. Pharmaceutics. 2022. PMID: 36015274 Free PMC article.
-
Synthesis of α,ω-bis-Mercaptoacyl Poly(alkyl oxide)s and Development of Thioether Cross-Linked Liposome Scaffolds for Sustained Release of Drugs.Molecules. 2024 Mar 15;29(6):1312. doi: 10.3390/molecules29061312. Molecules. 2024. PMID: 38542952 Free PMC article.
-
Biomembrane-Derived Nanoparticles in Alzheimer's Disease Therapy: A Comprehensive Review of Synthetic Lipid Nanoparticles and Natural Cell-Derived Vesicles.Int J Nanomedicine. 2023 Dec 7;18:7441-7468. doi: 10.2147/IJN.S436774. eCollection 2023. Int J Nanomedicine. 2023. PMID: 38090364 Free PMC article. Review.
-
Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.Chem Rev. 2021 Feb 24;121(4):2545-2647. doi: 10.1021/acs.chemrev.0c01122. Epub 2021 Feb 5. Chem Rev. 2021. PMID: 33543942 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous